CC BY-NC-ND 4.0 · Indian Journal of Neurotrauma 2020; 17(02): 069-073
DOI: 10.1055/s-0040-1713078
Review Article

The Role of Microglia in Cerebral Traumatic Injury and its Therapeutic Implications

Huber S. Padilla-Zambrano
1   Biomedical Research Center (CIB), Cartagena Neurotrauma Research Group Research Line, Faculty of Medicine, University of Cartagena, Cartagena, Colombia
,
2   Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India
,
Mohamed Arnout
3   Zagazig University, Zagazig, Egypt
,
Romario Mendoza-Florez
1   Biomedical Research Center (CIB), Cartagena Neurotrauma Research Group Research Line, Faculty of Medicine, University of Cartagena, Cartagena, Colombia
,
Wiston Eduardo Cardenas-Chavez
1   Biomedical Research Center (CIB), Cartagena Neurotrauma Research Group Research Line, Faculty of Medicine, University of Cartagena, Cartagena, Colombia
,
Monica Patricia Herrera-Martinez
1   Biomedical Research Center (CIB), Cartagena Neurotrauma Research Group Research Line, Faculty of Medicine, University of Cartagena, Cartagena, Colombia
,
Michael Gregorio Ortega-Sierra
4   Rafael Núñez University Corporation, Cartagena de Indias, Colombia
,
Amit Agrawal
5   Department of Neurosurgery, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
,
Luis Rafael Moscote-Salazar
1   Biomedical Research Center (CIB), Cartagena Neurotrauma Research Group Research Line, Faculty of Medicine, University of Cartagena, Cartagena, Colombia
› Author Affiliations
Funding None.

Abstract

Microglia have a variety of functions in the brain such as synaptic remodeling, damage repair of the central nervous system (CNS), and CNS’ inflammatory response to peripheral infections. The response depends on the type of insult and infection and includes a range of variety of activation states, the duration of which will decide the outcome. In response to traumatic brain injury (TBI), early activation can lead to early restoration of function, while prolonged and continuous activation can cause neurodegeneration states. Current evidence, however, states that this may not be the case. In this article, we discuss this seldom understood topic of microglia response to TBI, and analyze their distribution, function and possible sites of manipulation. Animal studies have allowed genetic and pharmacological manipulations of microglia activation, in order to define their role. Microglia activation can be remote to the site of injury, and thus their manipulation may play a significant role in the response to any trauma.



Publication History

Article published online:
02 September 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Cullheim S, Thams S. The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Res Brain Res Rev 2007; 55 (01) 89-96
  • 2 Ginhoux F, Prinz M. Origin of microglia : current concepts and past controversies. Cold Spring Harb Perspect Biol 2017; 1-16
  • 3 Casano AM, Peri F. Microglia: multitasking specialists of the brain. Dev Cell 2015; 32 (04) 469-477
  • 4 Kim J-Y, Kim N, Yenari MA. Mechanisms and potential therapeutic applications of microglial activation after brain injury. CNS Neurosci Ther 2015; 21 (04) 309-319
  • 5 Sundal C. Microglia: multiple roles in surveillance, circuit shaping, and response to injury. Neurology 2014; 82 (20) 1846
  • 6 Eyo UB, Dailey ME. Microglia: key elements in neural development, plasticity, and pathology. J Neuroimmune Pharmacol 2013; 8 (03) 494-509
  • 7 Loane DJ, Byrnes KR. Role of microglia in neurotrauma. Neurotherapeutics 2010; 7 (04) 366-377
  • 8 Wolf SA, Boddeke HWGM, Kettenmann H. Microglia in physiology and disease. Annu Rev Physiol 2017; 79 (01) 619-643
  • 9 Streit WJ. Microglial-neuronal interactions. J Chem Neuroanat 1993; 6 (04) 261-266
  • 10 Chen Z, Trapp BD. Microglia and neuroprotection. J Neurochem 2016; 136 (Suppl. 01) 10-17
  • 11 Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol 2014; 32 (01) 367-402
  • 12 Michell-Robinson MA, Touil H, Healy LM. et al. Roles of microglia in brain development, tissue maintenance and repair. Brain 2015; 138 (Pt 5) 1138-1159
  • 13 Streit WJ, Conde JR, Fendrick SE, Flanary BE, Mariani CL. Role of microglia in the central nervous system’s immune response. Neurol Res 2005; 27 (07) 685-691
  • 14 Kierdorf K, Prinz M. Factors regulating microglia activation. Front Cell Neurosci 2013; 7 (April) 44
  • 15 Lozano D, Gonzales-Portillo GS, Acosta S. et al. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat 2015; 11: 97-106
  • 16 Das M, Mohapatra S, Mohapatra SS. New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflammation 2012; 9 (01) 236
  • 17 Mannix RC, Whalen MJ. Traumatic brain injury, microglia, and Beta amyloid. Int J Alzheimers Dis 2012; 2012: 608732
  • 18 McGinn MJ, Povlishock JT. Pathophysiology of traumatic brain injury. Neurosurg Clin N Am 2016; 27 (04) 397-407
  • 19 Guerriero RM, Giza CC, Rotenberg A. Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep 2015; 15 (05) 27
  • 20 Zhou X, He X, Ren Y. Function of microglia and macrophages in secondary damage after spinal cord injury. Neural Regen Res 2014; 9 (20) 1787-1795
  • 21 Chhor V, Moretti R, Le Charpentier T. et al. Role of microglia in a mouse model of paediatric traumatic brain injury. Brain Behav Immun 2017; 63: 197-209
  • 22 Zhang Z, Zhang Z-Y, Wu Y, Schluesener HJ. Lesional accumulation of CD163+ macrophages/microglia in rat traumatic brain injury. Brain Res 2012; 1461: 102-110
  • 23 Hernandez-Ontiveros DG, Tajiri N, Acosta S, Giunta B, Tan J, Borlongan CV. Microglia activation as a biomarker for traumatic brain injury. Front Neurol 2013; 4: 30
  • 24 Donat CK, Scott G, Gentleman SM, Sastre M. Microglial activation in traumatic brain injury. Front Aging Neurosci 2017; 9 (JUN) 208
  • 25 Rathbone ATL, Tharmaradinam S, Jiang S, Rathbone MP, Kumbhare DA. A review of the neuro- and systemic inflammatory responses in post concussion symptoms: Introduction of the “post-inflammatory brain syndrome” PIBS. Brain Behav Immun 2015; 46: 1-16
  • 26 Balu R. Inflammation and immune system activation after traumatic brain injury. Curr Neurol Neurosci Rep 2014; 14 (10) 484
  • 27 Trahanas DM, Cuda CM, Perlman H, Schwulst SJ. Differential activation of infiltrating monocyte-derived cells after mild and severe traumatic brain injury. Shock 2015; 43 (03) 255-260
  • 28 Zhang G, Li Q, Wang L. et al. Traumatic brain injury induces macrophage subsets in the brain. Nephrol Dial Transplant 2013; 34 (01) 202
  • 29 Smith C. Review: the long-term consequences of microglial activation following acute traumatic brain injury. Neuropathol Appl Neurobiol 2013; 39 (01) 35-44
  • 30 Lull ME, Block ML. Microglial activation and chronic neurodegeneration. Neurotherapeutics 2010; 7 (04) 354-365
  • 31 Menzel L, Kleber L, Friedrich C. et al. Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury. Glia 2017; 65 (02) 278-292
  • 32 Hanlon LA, Huh JW, Raghupathi R. Minocycline transiently reduces microglia/macrophage activation but exacerbates cognitive deficits following repetitive traumatic brain injury in the neonatal rat. J Neuropathol Exp Neurol 2016; 75 (03) 214-226
  • 33 Kovesdi E, Kamnaksh A, Wingo D. et al. Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury. Front Neurol 2012; 3: 111
  • 34 Besson VC, Chen XR, Plotkine M, Marchand-Verrecchia C. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury. Neurosci Lett 2005; 388 (01) 7-12
  • 35 Wang G, Jiang X, Pu H. et al. Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway: scriptaid protects against TBI via AKT. Neurotherapeutics 2013; 10 (01) 124-142